Deane Retirement Strategies’s Biogen BIIB Stock Holding History

Deane Retirement Strategies’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,575	Closed	-$1.62M	–	55
2018 Q3	$1.62M	Sell	4,575 -6	-0.1%	-$2.07K	1.46%	29
2018 Q2	$1.33M	Buy	4,581 +69	+2%	+$19.4K	1.26%	33
2018 Q1	$1.24M	Buy	4,512 +70	+2%	+$21.7K	1.26%	34
2017 Q4	$1.42M	Sell	4,442 -119	-3%	-$38.2K	1.31%	35
2017 Q3	$1.43M	Sell	4,561 -102	-2%	-$30.2K	1.38%	28
2017 Q2	$1.26M	Buy	+4,663	New	+$1.23M	1.01%	38
2015 Q2	–	Sell	-63,827	Closed	-$1.69M	–	43
2015 Q1	$1.69M	Buy	+63,827	New	+$25.2M	1.63%	17

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deane Retirement Strategies's BIIB Position: Q4 2018 in Review

Deane Retirement Strategies sold out of Biogen (BIIB) in Q4 2018, closing a stake of 4,575 shares — an estimated $1.62M sold.

Deane Retirement Strategies first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $1.69M in Q1 2015. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Deane Retirement Strategies reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Deane Retirement Strategies sold 4,575 Biogen shares in Q4 2018, an estimated $1.62M.
Deane Retirement Strategies first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
Deane Retirement Strategies's Biogen position peaked at $1.69M in Q1 2015.
1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Deane Retirement Strategies's 13F filing for Q4 2018, filed 10 Jan 2019.